Breast cancer increases osteoclastogenesis by secreting M-CSF and upregulating RANKL in stromal cells

Journal of Surgical Research

Volumn 100, Issue 1, 2001, Pages 18-24

  Mancino, Anne T ^a   Klimberg, V Suzanne ^a   Yamamoto, Matsuo ^a   Manolagas, Stavros C ^a   Abe, Etsuko ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Bone metastasis; Breast cancer; M CSF; MDA MB 231; Osteoclastogenesis; RANKL

Indexed keywords

COLONY STIMULATING FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; RECOMBINANT COLONY STIMULATING FACTOR 1;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BONE METASTASIS; BREAST CANCER; COCULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NORTHERN BLOTTING; OSTEOCLAST; PRIORITY JOURNAL; STROMA CELL;

EID: 0034861109     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.2001.6204     Document Type: Article

References (49)

1. The clinical course of bone metastases from breast cancer
2. Mechanisms of bone metastasis
3. Histomorphometric evidence for osteoclast-mediated resorption in metastatic breast cancer
4. Parathyroid hormone-related protein and bone disease
5. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis
6. Cytokines and growth factors in the regulation of bone remodeling
7. Osteolytic bone metastasis in breast cancer
8. Nuclear factor κB (NF-κB), nuclear factor interleukin-6 (NFIL-6 or C/EBPβ) and nuclear factor interleukin-6β (NFIL-6-β or C/EBPδd) are not sufficient to activate the endogenous interleukin-6 gene in the human breast carcinoma cell line MCF-7. Comparative analysis with MDA-MB-231 cells, an interleukin-6-expressing human breast carcinoma cell line
9. Prostaglandin E2 production and metabolism in human breast cancer cells and breast fibroblasts. Regulation by inflammatory mediators
10. Production and regulation of interleukin-11 by breast cancer cells
11. Breast cancer cells interact with osteoblasts to support osteoclast formation
12. Interactions between cancer and bone marrow cells induce osteoclast differentiation factor expression and osteoclast-like cell formation in vitro
13. Human breast cancer induces osteoclast activation and increases the number of osteoclasts at sites of tumor osteolysis
14. Bisphosphonate rise-dronate reduces metastatic human breast cancer burden in nude mice
15. Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2
16. Efficacy of pamidronate in reducing skeletal complication in patients with breast cancer and lytic bone metastasis
17. Reduction in new metastasis in breast cancer with adjuvant clodronate treatment
18. Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures
19. Osteoblastic cells are involved in osteoclast formation
20. A combination of osteoclast differentiation factor and macrophage - Colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro
21. Murine osteoblast-like cells and the osteogenic cell MC3T3-E 7 release a macrophage colony stimulating activity in culture
22. Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors
23. Macrophage colony stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse
24. Prostaglandin E2, interleukin 1α and tumor necrosis factor-α increase human osteoclast formation and bone resorption in vitro
25. Macrophage colony-stimulating factor induces substantial osteoclast generation and bone resorption in human bone marrow cultures
26. Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1alpha,25-dihidroxyvitamin D 3, prostaglandin E2 or parathyroid hormone in the microenvironment of bone
27. Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic cells
28. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
29. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation
30. A murine model of experimental metastasis to bone and bone marrow
31. Breast tumor cell lines from pleural effusions
32. Inhibition of Osf2/Cbfa 1 expression and terminal osteoblast differentiation
33. Single-step method of RNA isolation by acid guanidium thiocyanate - Phenol - Chloroform extraction
34. Detection of receptors for interleukin-6, interleukin-11, leukemia inhibitory factor, oncostatin M and ciliary neurotropic factor in bone marrow stromal/osteoblastic cells
35. 1a,25-Dihydroxyvitamin D3 promotes fusion of mouse alveolar macrophages both by a direct mechanism and by a spleen cell-mediated indirect mechanism
36. CSF-1 and C-FMS gene expression in human carcinoma cell lines
37. Constitutive production of macrophage colony-stimulating factor by human ovarian and breast cancer cell lines
38. Stimulation of interleukin-11 production from osteoblast-like cells by transforming growth factor-β and tumor cell factors
39. Identification of breast cancer cell line-derived paracrine factors that stimulate osteoclast activity
40. Macrophage colony-stimulating factor increases bone resorption by osteoclasts disaggregated from human fetal long bones
41. Macrophage colony stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts
42. Macrophage colony-stimulating factor and interleukin-1α maintain the survival of osteoclast-like cells
43. Regulation of osteoclast function
44. CSF- 1 and its receptor in breast carcinomas
45. RFS (CSF-1 receptor) and neoplasms of the female reproductive tract
46. Expression of colony-stimulating factor-1 and its receptor (the protein product of c-fms) in invasive breast tumor cells: Induction of urokinase production via this pathway?
47. M-CSF (monocyte colony stimulating factor) and M-CSF receptor expression by breast tumour cells: M-CSF mediated recruitment of tumour infiltrating monocytes?
48. Macrophage colony-stimulating factor (CSF-1) enhances invasiveness in CSF-1 receptor positive carcinoma cell lines
49. Circulating levels of the macrophage colony stimulating factor CSF-1 in primary and metastatic breast cancer patients. A pilot study